Saudi Press

Saudi Arabia and the world
Saturday, Aug 23, 2025

European Union Turns To Pfizer After Johnson & Johnson Vaccine Suspension

European Union Turns To Pfizer After Johnson & Johnson Vaccine Suspension

BioNTech/Pfizer is bringing forward delivery of 50 million doses to the second quarter, starting this month, to help make up for the shortfall of the J&J jabs that were meant to start rolling out, she said in a televised statement.

The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.

BioNTech/Pfizer is bringing forward delivery of 50 million doses to the second quarter, starting this month, to help make up for the shortfall of the J&J jabs that were meant to start rolling out, she said in a televised statement.

The European Union is also negotiating with BioNTech/Pfizer for 1.8 billion doses of a second-generation of its mRNA vaccine to combat variants, to be delivered in 2022 and 2023, she said.

"As we can see, with the announcement by Johnson & Johnson yesterday, there are still many factors that can disrupt the planned delivery schedules of vaccines," she said, referring to the company's decision to suspend European deliveries while rare blood clot cases possibly linked to its shot are investigated in the United States.

"It is therefore important to act swiftly, anticipate and adjust whenever it is possible," she said, announcing the second-quarter delivery of 50 million BioNTech/Pfizer doses originally scheduled for the fourth quarter of this year.

Von der Leyen said that would bring the total number of BioNTech/Pfizer doses for April, May and June to 250 million -- accounting for more than half of all jabs to be given in this quarter.

"I think this will substantially help consolidate the rollout of our vaccination campaigns," she said, noting that there have already been 100 million doses given in the bloc to date, with 27 million people fully vaccinated.

The European Union had a sluggish first-quarter rollout mainly because of vaccine supply constraints, especially by AstraZeneca which delivered less than a quarter of the 120 million doses it had promised.

Virus variants


Question marks are now above the adenovirus-type vaccines produced by AstraZeneca and Johnson & Johnson in the wake of suspected blood clots.

While the European Medicines Agency has authorised AstraZeneca for all adults, many EU countries have taken the precaution of limiting its use to only older segments of the population.

Von der Leyen made clear that BioNTech/Pfizer was increasingly the go-to supplier for the bloc, with no health problems so far associated with its mRNA vaccine which has proven to be highly effective against the main strains of the coronavirus present in the EU.

However there are concerns about emerging virus variants that could dampen the effect of current vaccines.

Von der Leyen said to address that, "at a certain point in time, we might need booster jabs to reinforce and prolong immunity" with vaccines that are effective against mutations.

"We need to focus now on technologies that have proven their worth: mRNA vaccines are a clear case in point. And based on all this, we are now entering into negotiations with BioNTech/Pfizer for a third contract," she said.

That would foresee the delivery of 1.8 billion second-generation BioNTech/Pfizer vaccine doses over next year and 2023.

"It will entail not only the production of vaccines, but also the essential components. All of that will be based in the European Union," von der Leyen said, indirectly referencing concerns that had arisen about supplies of AstraZeneca from Britain or Johnson & Johnson doses that were sent via the US for packaging.

The EU has made the production of vaccines on its territory -- already the main vaccine manufacturing powerhouse in the world alongside the US -- a condition of its forthcoming contracts.

"Other contracts with other companies may follow," von der Leyen said.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Dogfights in the Skies: Airbus on Track to Overtake Boeing and Claim Aviation Supremacy
Tim Cook Promises an AI Revolution at Apple: "One of the Most Significant Technologies of Our Generation"
Are AI Data Centres the Infrastructure of the Future or the Next Crisis?
Miles Worth Billions: How Airlines Generate Huge Profits
Zelenskyy Returns to White House Flanked by European Allies as Trump Pressures Land-Swap Deal with Putin
Beijing is moving into gold and other assets, diversifying away from the dollar
Cristiano Ronaldo Makes Surprise Stop at New Hong Kong Museum
Zelenskyy to Visit Washington after Trump–Putin Summit Yields No Agreement
High-Stakes Trump-Putin Summit on Ukraine Underway in Alaska
Iranian Protection Offers Chinese Vehicle Shipments a Cost Advantage over Japanese and Korean Makers
Saudi Arabia accelerates renewables to curb domestic oil use
Cristiano Ronaldo and Georgina Rodríguez announce engagement
Asia-Pacific dominates world’s busiest flight routes, with South Korea’s Jeju–Seoul corridor leading global rankings
Private Welsh island with 19th-century fort listed for sale at over £3 million
Sam Altman challenges Elon Musk with plans for Neuralink rival
Australia to Recognize the State of Palestine at UN Assembly
The Collapse of the Programmer Dream: AI Experts Now the Real High-Earners
Armenia and Azerbaijan to Sign US-Brokered Framework Agreement for Nakhchivan Corridor
British Labour Government Utilizes Counter-Terrorism Tools for Social Media Monitoring Against Legitimate Critics
WhatsApp Deletes 6.8 Million Scam Accounts Amid Rising Global Fraud
Nine people have been hospitalized and dozens of salmonella cases have been reported after an outbreak of infections linked to certain brands of pistachios and pistachio-containing products, according to the Public Health Agency of Canada
Texas Residents Face Water Restrictions While AI Data Centers Consume Millions of Gallons
Tariffs, AI, and the Shifting U.S. Macro Landscape: Navigating a New Economic Regime
India Rejects U.S. Tariff Threat, Defends Russian Oil Purchases
United States Establishes Strategic Bitcoin Reserve and Digital Asset Stockpile
Thousands of Private ChatGPT Conversations Accidentally Indexed by Google
China Tightens Mineral Controls, Curtailing Critical Inputs for Western Defence Contractors
OpenAI’s Bold Bet: Teaching AI to Think, Not Just Chat
BP’s Largest Oil and Gas Find in 25 Years Uncovered Offshore Brazil
JPMorgan and Coinbase Unveil Partnership to Let Chase Cardholders Buy Crypto Directly
British Tourist Dies Following Hair Transplant in Turkey, Police Investigate
WhatsApp Users Targeted in New Scam Involving Account Takeovers
Trump Deploys Nuclear Submarines After Threats from Former Russian President Medvedev
Germany’s Economic Breakdown and the Return of Militarization: From Industrial Collapse to a New Offensive Strategy
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Russia Formally Recognizes Taliban Government in Afghanistan
×